Cargando…

NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease

Dry eye disease (DED) is a multifactorial ocular surface disorder arising from numerous interrelated underlying pathologies that trigger a self-perpetuating cycle of instability, hyperosmolarity, and ocular surface damage. Associated ocular discomfort and visual disturbance contribute negatively to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Dian, Misra, Stuti L., Mugisho, Odunayo O., Rupenthal, Ilva D., Craig, Jennifer P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341612/ https://www.ncbi.nlm.nih.gov/pubmed/37446038 http://dx.doi.org/10.3390/ijms241310866

Ejemplares similares

Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
por: Kuo, Charisse Y-J., et al.
Publicado: (2022)

Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review
por: Kuo, Charisse Y. J., et al.
Publicado: (2022)

Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy
por: Lyon, Heather, et al.
Publicado: (2020)

Characterization of Zinc Oxide Nanoparticle Cross-Linked Collagen Hydrogels
por: Agban, Yosra, et al.
Publicado: (2020)

Formulation Considerations for the Management of Dry Eye Disease
por: Agarwal, Priyanka, et al.
Publicado: (2021)

Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy
por: Mugisho, Odunayo O., et al.
Publicado: (2023)

Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
por: Shome, Avik, et al.
Publicado: (2023)

Connexin therapeutics: blocking connexin hemichannel pores is distinct from blocking pannexin channels or gap junctions
por: Acosta, Monica L., et al.
Publicado: (2020)

Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas
por: Mugisho, Odunayo O., et al.
Publicado: (2017)

Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy
por: Mugisho, Odunayo O., et al.
Publicado: (2018)

Upregulation of NLRP3 Inflammasome in the Tears and Ocular Surface of Dry Eye Patients
por: Niu, Liangliang, et al.
Publicado: (2015)

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
por: Tezcan, Gulcin, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
por: Liang, Tao, et al.
Publicado: (2022)

hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye
por: Yu, Chaoqun, et al.
Publicado: (2020)

NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2023)

The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
por: O’Brien, William T., et al.
Publicado: (2020)

The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury
por: Ismael, Saifudeen, et al.
Publicado: (2020)

NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2023)

NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy
por: Tsai, Yu-Ling, et al.
Publicado: (2017)

The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
por: Li, Jiayue, et al.
Publicado: (2023)

The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
por: Chen, Ruixiang, et al.
Publicado: (2021)

The NLRP3 Inflammasome: Role and Therapeutic Potential in Pain Treatment
por: Starobova, Hana, et al.
Publicado: (2020)

The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches
por: Mauro, Adolfo G., et al.
Publicado: (2021)

Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases
por: Mat Nor, Mohd N., et al.
Publicado: (2021)

The Potential Therapeutic Role of miR-223 in Bovine Endometritis by Targeting the NLRP3 Inflammasome
por: Zhao, Gan, et al.
Publicado: (2018)

TI: NLRP3 Inflammasome-Dependent Pyroptosis in CNS Trauma: A Potential Therapeutic Target
por: Zhou, Conghui, et al.
Publicado: (2022)

NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
por: Zhang, Yun, et al.
Publicado: (2020)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
por: Wu, Dantong, et al.
Publicado: (2021)

NLRP3 inflammasome as a novel therapeutic target for heart failure
por: Wang, Shuangcui, et al.
Publicado: (2021)

The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis
por: Fan, Jiwen, et al.
Publicado: (2022)

Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2023)

Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer
por: Wang, Xixi, et al.
Publicado: (2023)

Targeting the NLRP3 Inflammasome in Glaucoma
por: Coyle, Sophie, et al.
Publicado: (2021)

NLRP3 inflammasome: A joint, potential therapeutic target in management of COVID-19 and fertility problems
por: Bazrafkan, Mahshid, et al.
Publicado: (2021)

NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity
por: Wei, Shanshan, et al.
Publicado: (2021)

Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
por: Missiroli, Sonia, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
por: Bai, Rongrong, et al.
Publicado: (2021)

NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder
por: Kouba, Bruna R., et al.
Publicado: (2022)

Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study
por: Ali, Fares E.M, et al.
Publicado: (2023)

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
por: Guan, Yadi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fc1u93kl6ftn7gt2n18clvhpd7